Drugs · Entity Annotation Prototype (beta)

1articles mentioning drugs

4drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: DuoCAR20.19.22-D95 ×

DuoCAR20.19.22-D95

This drug is selected. Its supporting articles are shown below.

DuoCAR20.19.22-D951

Articles mentioning DuoCAR20.19.22-D95

1 articles · page 1 of 1

555 Flow cytometry-based lower limit of quantitation (LLOQ) validation for detection of DuoCAR20.19.22-D95 CAR T cells in support of a phase 1/2 clinical trial for B-cell malignancies

jitc · abstract · 2025-11-04 · 4 matching annotations

95.4%

DuoCAR20.19.22-D95 relapsed or refractory B-cell malignancies

…istence, and minimal residual disease (MRD) in clinical trials. DuoCAR20.19.22-D95 is an investigational autologous CAR T-cell therapy targeting C…

Browse drugs

DuoCAR20.19.22-D95

Articles mentioning DuoCAR20.19.22-D95

555 Flow cytometry-based lower limit of quantitation (LLOQ) validation for detection of DuoCAR20.19.22-D95 CAR T cells in support of a phase 1/2 clinical trial for B-cell malignancies